Exercise-induced Bronchospasm
📧 Sign up to get email alerts when something new happens for Exercise-induced Bronchospasm.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Swiss Paediatric Airway Cohort
Update on the Swiss Paediatric Airway Cohort. The study is currently recruiting participants for a pediatric airway investigation addressing…
-
FDA approval · 2025-12-01FDA Approved: ALBUTEROL SULFATE INHALATION — Original Application (Amneal Pharmaceuticals NY LLC)
FDA approved Amneal's albuterol sulfate inhalation as a generic inhalation product under ANDA 211600 for relief of bronchospasm in reversibl…
-
CLINICAL_TRIALS research · 2024-06-28Clinical Trial Update: Prevalence of EILO Among Children With Asthma [NA]
A clinical trial update describes a study to determine how prevalent exercise-induced laryngeal obstruction is among children with asthma; t…
-
FDA approval · 2024-05-03FDA Approved: ALBUTEROL SULFATE — Original Application (Ingenus Pharmaceuticals, LLC)
FDA approves Ingenus Pharmaceuticals' original application for albuterol sulfate as a generic inhalation product. The approved indication co…
-
FDA approval · 2023-08-28FDA Approved: PROAIR DIGIHALER — Supplemental Application (Teva Respiratory, LLC)
FDA approved a supplemental application for ProAir Digihaler (albuterol sulfate) from Teva Respiratory, LLC. The approval covers changes rel…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2023-05-08FDA Approved: ALBUTEROL SULFATE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for albuterol sulfate submitted by Mylan Pharmaceuticals Inc. under ANDA214531. This action adds…
-
CLINICAL_TRIALS trial_result · 2021-12-30Clinical Trial Update: A Study to Assess the Efficacy of Budesonide/Albuterol Metered-dose Inhaler (BDA MDI/PT027) on Exercise-induced Bronchoconstriction in Adults and Adolescents With Asthma [Phase 3]
Phase 3 trial assessing budesonide/albuterol MDI for exercise-induced bronchoconstriction in adults and adolescents with asthma has complete…
-
CLINICAL_TRIALS trial_result · 2021-11-24Clinical Trial Update: Comparison of Two Bronchodilator Inhalers in Adolescents and Adults With Exercise-Induced Asthma [Phase 3]
Phase 3 trial comparing two bronchodilator inhalers in adolescents and adults with exercise-induced bronchospasm has completed.
-
FDA approval · 2021-01-14FDA Approved: ALBUTEROL SULFATE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved a supplemental application from Lupin Pharmaceuticals for albuterol sulfate, confirming approval of a generic inhalation produc…
-
FDA approval · 2020-04-20FDA Approved: ALBUTEROL SULFATE — Original Application (Luoxin Aurovitas Pharma (Chengdu) Co., Ltd.)
The FDA approved an original application for a generic albuterol sulfate product by Luoxin Aurovitas Pharma (Chengdu) Co., Ltd., authorizing…
-
FDA approval · 2019-03-15FDA Approved: ALBUTEROL — Original Application (Nivagen Pharmaceuticals Inc)
FDA approves the original ANDA for albuterol sulfate (albuterol) from Nivagen Pharmaceuticals Inc, making a generic albuterol product availa…
-
FDA approval · 2019-01-09FDA Approved: PROAIR DIGIHALER — Supplemental Application (Teva Respiratory, LLC)
The FDA approved a supplemental application for PROAIR DIGIHALER (albuterol sulfate) submitted by Teva Respiratory, LLC. This action updates…
-
FDA approval · 2018-05-21FDA Approved: ALBUTEROL — Original Application (Amneal Pharmaceuticals NY LLC)
The FDA approved the original application for albuterol from Amneal Pharmaceuticals NY LLC, enabling a generic albuterol inhalation product …
-
FDA label_change · 2016-11-09FDA Approved: ALBUTEROL SULFATE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for ALBUTEROL SULFATE from Sandoz Inc, resulting in changes to the product labeling.
-
CLINICAL_TRIALS trial_result · 2016-10-31Clinical Trial Update: Role of Leukotrienes and Adenosine in Hyperpnea-induced Bronchospasm
A completed clinical trial evaluating the roles of leukotrienes and adenosine in hyperpnea-induced bronchospasm related to exercise-induced …
-
CLINICAL_TRIALS trial_result · 2016-05-12Clinical Trial Update: Diagnosis of Exercise-induced Bronchospasm (EIB) and Asthma in National Collegiate Athletic Association (NCAA) Division I Athletes
A completed clinical trial examining the diagnosis of exercise-induced bronchospasm and asthma in NCAA Division I athletes.
-
CLINICAL_TRIALS withdrawal · 2016-01-07Clinical Trial Update: Effects of Montelukast on Occult Exercise-Induced Bronchospasm in Athletes [NA]
A clinical trial evaluating montelukast for occult exercise-induced bronchospasm in athletes has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-12-11Clinical Trial Update: Bronchoprotective Effect of Arformoterol in Children With Exercise-Induced Bronchospasm (EIB) [Phase 3]
A Phase 3 clinical trial evaluating arformoterol for bronchoprotective effect in children with exercise-induced bronchospasm has been withdr…
-
FDA approval · 2015-08-14FDA Approved: VENTOLIN HFA — Supplemental Application (GlaxoSmithKline LLC)
FDA approved a supplemental application for Ventolin HFA (albuterol sulfate) from GlaxoSmithKline LLC.
-
FDA approval · 2014-06-17FDA Approved: VENTOLIN HFA — Supplemental Application (GlaxoSmithKline LLC)
FDA approved a supplemental application for Ventolin HFA (albuterol sulfate) submitted by GlaxoSmithKline LLC.
-
FDA approval · 2013-04-04FDA Approved: CROMOLYN SODIUM — Original Application (Micro Labs Limited)
FDA approved Micro Labs Limited's original ANDA for cromolyn sodium.
-
FDA approval · 2013-02-19FDA Approved: LEVALBUTEROL — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application from Mylan Pharmaceuticals Inc. for Levalbuterol, confirming the availability of a generic bronc…
-
FDA approval · 2013-01-09FDA Approved: ALBUTEROL SULFATE HFA — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for ALBUTEROL SULFATE HFA from Teva Pharmaceuticals USA, Inc., related to this albuterol sulfate…
-
FDA approval · 2012-06-05FDA Approved: ALBUTEROL SULFATE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for albuterol sulfate by Sandoz Inc under NDA 020503, signaling an approved modification to the exis…
-
CLINICAL_TRIALS trial_result · 2012-02-22Clinical Trial Update: Efficacy Study of Single-Dose Levalbuterol Tartrate HFA MDI Vs Placebo in Subjects 18 Years and Older With EIB [Phase 3]
Phase 3 efficacy study comparing a single-dose levalbuterol tartrate HFA MDI to placebo in adults with exercise-induced bronchospasm has com…